Metals and breast cancer: Risk factors or healing agents?

Journal of Toxicology

Volumn 2011, Issue , 2011, Pages

  Büsselberg, Dietrich ^b   Florea, Ana Maria ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; CADMIUM; CISPLATIN; CYMANTRENE; GOLD NANOPARTICLE; LEAD; METAL; PEPTIDE DERIVATIVE; PLATINUM; SELENIUM; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER RISK; CANCER THERAPY; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SOLID TUMOR;

EID: 80052672049     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2011/159619     Document Type: Article

References (56)

1. WHO F. S.,. 2011, http://www.who.int/mediacentre/factsheets/fs297/en/ index.html
2. Gallagher C. M., Chen J. J., Kovach J. S., Environmental cadmium and breast cancer risk Aging 2010 2 11 804 814
3. Wood R. Y., Della-Monica N. R., Psychosocial factors influencing breast cancer risk appraisal among older women Qualitative Health Research 2011 21 6 783 795
4. Jevtic M., Velicki R., Popovic M., Cemerlic-Adjic N., Babovic S. S., Velicki L., Dietary influence on breast cancer Journal of B.U.ON. 2010 15 3 455 461
5. Salhab M., Bismohun S., Mokbel K., Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery BMC Women's Health 2010 10, article 28
6. Atkinson R. L., Zhang M., Diagaradjane P., Peddibhotla S., Contreras A., Hilsenbeck S. G., Woodward W. A., Krishnan S., Chang J. C., Rosen J. M., Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy Science Translational Medicine 2010 2 55
7. Okoh V., Deoraj A., Roy D., Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer Biochimica et Biophysica Acta 2011 1815 1 115 133
8. Siewit C. L., Gengler B., Vegas E., Puckett R., Louie M. C., Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ER and c-Jun Molecular Endocrinology 2010 24 5 981 992
9. McElroy J. A., Shafer M. M., Trentham-Dietz A., Hampton J. M., Newcomb P. A., Cadmium exposure and breast cancer risk Journal of the National Cancer Institute 2006 98 12 869 873 (Pubitemid 43923443)
10. Benbrahim-Tallaa L., Tokar E. J., Diwan B. A., Dill A. L., Coppin J. F., Waalkes M. P., Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype Environmental Health Perspectives 2009 117 12 1847 1852
11. Florea A.-M., Bsselberg D., Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects Cancers 2011 3 1 1351 1371
12. Silvera S. A. N., Rohan T. E., Trace elements and cancer risk: a review of the epidemiologic evidence Cancer Causes and Control 2007 18 1 7 27 (Pubitemid 46020898)
13. Florea A. M., Bsselberg D., Occurrence, use and potential toxic effects of metals and metal compounds BioMetals 2006 19 4 419 427
14. Schrauzer G. N., Interactive effects of selenium and cadmium on mammary tumor development and growth in MMTV-Infected female mice. A model study on the roles of cadmium and selenium in human breast cancer Biological Trace Element Research 2008 123 13 27 34
15. Choe S. Y., Kim S. J., Kim H. G., Lee J. H., Choi Y., Lee H., Kim Y., Evaluation of estrogenicity of major heavy metals Science of the Total Environment 2003 312 13 15 21 (Pubitemid 36836198)
16. Saleh F., Behbehani A., Asfar S., Khan I., Ibrahim G., Abnormal blood levels of trace elements and metals, DNA damage, and breast cancer in the state of Kuwait Biological Trace Element Research 2010 1 14
17. Cui Y., Vogt S., Olson N., Glass A. G., Rohan T. E., Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer Cancer Epidemiology Biomarkers and Prevention 2007 16 8 1682 1685 (Pubitemid 47294838)
18. Ying S., Myers K., Bottomley S., Helleday T., Bryant H. E., BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells Nucleic Acids Research 2009 37 15 5105 5113
19. Florea A. M., Bsselberg D., Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells Toxicology Letters 2008 179 1 34 42
20. Florea A. M., Splettstoesser F., Bsselberg D., Arsenic trioxide (As2O3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK) Toxicology and Applied Pharmacology 2007 220 3 292 301 (Pubitemid 46627846)
21. Ruiz-Ramos R., Lopez-Carrillo L., Rios-Perez A. D., De Vizcaya-Ruz A., Cebrian M. E., Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF- B activation and cell proliferation in human breast cancer MCF-7 cells Mutation Research 2009 674 1-2 109 115
22. Ruiz-Ramos R., Lpez-Carrillo L., Albores A., Hernndez-Ramrez R. U., Cebrian M. E., Sodium arsenite alters cell cycle and MTHFR, MT1/2, and c-Myc protein levels in MCF-7 cells Toxicology and Applied Pharmacology 2009 241 3 269 274
23. Liu Y., Hock J. M., Sullivan C., Fang G., Cox A. J., Davis K. T., Davis B. H., Li X., Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation Journal of Cellular Biochemistry 2010 111 6 1546 1555
24. Wang X., Gao P., Long M., Lin F., Wei J. X., Ren J. H., Yan L., He T., Han Y., Zhang H. Z., Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Medical Oncology. In press
25. Ahn R. W., Chen F., Chen H., Stern S. T., Clogston J. D., Patri A. K., Raja M. R., Swindell E. P., Parimi V., Cryns V. L., O'Halloran T. V., A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer Clinical Cancer Research 2010 16 14 3607 3617
26. Wang T., Zhang S., Zeng M., Lu X., Shen G., Wu S., Song S., Jiang Z., Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Medical Oncology. In press
27. Pacini S., Punzi T., Morucci G., Gulisano M., Ruggiero M., A paradox of cadmium: a carcinogen that impairs the capability of human breast cancer cells to induce angiogenesis Journal of Environmental Pathology, Toxicology and Oncology 2009 28 1 85 88
28. Yu X., Filardo E. J., Shaikh Z. A., The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells Toxicology and Applied Pharmacology 2010 245 1 83 90
29. Martnez-Campa C., Alonso-Gonzlez C., Mediavilla M. D., Cos S., Gonzlez A., Ramos S., Snchez-Barcel E. J., Melatonin inhibits both ER activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium Journal of Pineal Research 2006 40 4 291 296
30. Sun X., Fontaine J. M., Bartl I., Behnam B., Welsh M. J., Benndorf R., Induction of Hsp22 (HspB8) by estrogen and the metalloestrogen cadmium in estrogen receptor-positive breast cancer cells Cell Stress and Chaperones 2007 12 4 307 319
31. Casano C., Agnello M., Sirchia R., Luparello C., Cadmium effects on p38/MAPK isoforms in MDA-MB231 breast cancer cells BioMetals 2010 23 1 83 92
32. Brama M., Gnessi L., Basciani S., Cerulli N., Politi L., Spera G., Mariani S., Cherubini S., d'Abusco A. S., Scandurra R., Migliaccio S., Cadmium induces mitogenic signaling in breast cancer cell by an ER -dependent mechanism Molecular and Cellular Endocrinology 2007 264 1-2 102 108 (Pubitemid 46110939)
33. Jain S., Coulter J. A., Hounsell A. R., Butterworth K. T., McMahon S. J., Hyland W. B., Muir M. F., Dickson G. R., Prise K. M., Currell F. J., O'Sullivan J. M., Hirst D. G., Cell-Specific Radiosensitization by gold nanoparticles at megavoltage radiation energies International Journal of Radiation Oncology Biology Physics 2011 79 2 531 539
34. Day E. S., Bickford L. R., Slater J. H., Riggall N. S., Drezek R. A., West J. L., Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer International Journal of Nanomedicine 2010 5 1 445 454
35. Wong S. W., Tiong K. H., Kong W. Y., Yue Y. C., Chua C. H., Lim J. Y., Lee C. Y., Quah S. I., Fow C., Chung C., So I., Tan B. S., Choo H. L., Rosli R., Cheong S. K., Leong C. O., Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73 Breast Cancer Research and Treatment 2011 128 2 301 313
36. Al-Taweel N., Varghese E., Bsselberg D., Cisplatin triggers cell death of MCF-7 cells following disruption of [Ca2+]i homeostasis Proceedings of the 3rd International Symposium on Metallomics 2011 Doha, Qatar
37. Splettstoesser F., Florea A. M., Bsselberg D., IP3 receptor antagonist, 2-APB, attenuates cisplatin induced Ca2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis British Journal of Pharmacology 2007 151 8 1176 1186 (Pubitemid 47255902)
38. Brito L. G. O., de Andrade J. M., Lins-Almeida T., Zola F. E., Pinheiro M. N., Marana H. R. C., Tiezzi D. G., Peria F. M., Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients. Medical Oncology. In press
39. de Lima Arajo L. H., Moitinho M. V., Silva A. M. F., Gomes C. A. S., Noronha Jnior H., Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience. Medical Oncology. In press
40. Xu L., Yin S., Banerjee S., Sarkar F., Reddy K. B., Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells Molecular Cancer Therapeutics 2011 10 3 550 557
41. Rowe R. W., Strebel F. R., Proett J. M., Deng W., Chan D., He G., Siddik Z., Bull J. M. C., Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model International Journal of Hyperthermia 2010 26 6 565 576
42. Mendes F., Groessl M., Nazarov A. A., Tsybin Y. O., Sava G., Santos I., Dyson P. J., Casini A., Metal-based inhibition of poly(ADP-ribose) polymerase-the guardian angel of DNA Journal of Medicinal Chemistry 2011 54 7 2196 2206
43. Dvok Z., tarha P., Trvnek Z., Evaluation of in vitro cytotoxicity of 6-benzylaminopurine carboplatin derivatives against human cancer cell lines and primary human hepatocytes Toxicology in Vitro 2011 25 3 652 656
44. Paraskar A. S., Soni S., Chin K. T., Chaudhuri P., Muto K. W., Berkowitz J., Handlogten M. W., Alves N. J., Bilgicer B., Dinulescu D. M., Mashelkar R. A., Sengupta S., Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy Proceedings of the National Academy of Sciences of the United States of America 2010 107 28 12435 12440
45. Muscella A., Calabriso N., Vetrugno C., Fanizzi F. P., De Pascali S. A., Storelli C., Marsigliante S., The platinum (II) complex [Pt(O,O'-acac)( -acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells Biochemical Pharmacology 2011 81 1 91 103
46. Alatise O. I., Schrauzer G. N., Lead exposure: a contributing cause of the current breast cancer epidemic in Nigerian Women Biological Trace Element Research 2010 136 2 127 139
47. Splith K., Hu W., Schatzschneider U., Gust R., Ott I., Onambele L. A., Prokop A., Neundorf I., Protease-activatable organometal-peptide bioconjugates with enhanced cytotoxicity on cancer cells Bioconjugate Chemistry 2010 21 7 1288 1296
48. Chen T., Wong Y. S., Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation International Journal of Biochemistry and Cell Biology 2009 41 3 666 676
49. Greenlee H., Gammon M. D., Abrahamson P. E., Gaudet M. M., Terry M. B., Hershman D. L., Desai M., Teitelbaum S. L., Neugut A. I., Jacobson J. S., Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project Cancer 2009 115 14 3271 3282
50. Suzana S., Cham B. G., Ahmad Rohi G., Mohd Rizal R., Fairulnizal M. N., Normah H., Fatimah A., Relationship between selenium and breast cancer: a case-control study in the Klang Valley Singapore Medical Journal 2009 50 3 265 269
51. Dziaman T., Huzarski T., Gackowski D., Rozalski R., Siomek A., Szpila A., Guz J., Lubinski J., Wasowicz W., Roszkowski K., Olinski R., Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers Cancer Epidemiology Biomarkers and Prevention 2009 18 11 2923 2928
52. Hawkes W. C., Wang T. T. Y., Alkan Z., Richter B. D., Dawson K., Selenoprotein W modulates control of cell cycle entry Biological Trace Element Research 2009 131 3 229 244
53. Li Z., Carrier L., Belame A., Thiyagarajah A., Salvo V. A., Burow M. E., Rowan B. G., Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis Breast Cancer Research and Treatment 2009 118 1 33 43
54. Li Z., Carrier L., Rowan B. G., Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells Molecular Cancer Therapeutics 2008 7 9 3056 3063
55. Li S., Zhou Y., Dong Y., Ip C., Doxorubicin and selenium cooperatively induce Fas signaling in the absence of Fas/Fas ligand interaction Anticancer Research 2007 27 5 A 3075 3082 (Pubitemid 47607529)
56. Li S., Zhou Y., Wang R., Zhang H., Dong Y., Ip C., Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates Molecular Cancer Therapeutics 2007 6 3 1031 1038 (Pubitemid 46554573)